Abstract: The present invention relates to a CD9-specific human antibody, more precisely a CD9-specific human antibody composed of human derived CD9-specific complementarity determining region (CDR) and framework region (FR). The human antibody of the present invention recognizes CD9 extracellular loop 2 domain (CD9-ECL2) as an epitope and thereby strongly binding thereto. The human antibody of the present invention also has CD9 antigen neutralizing effect and at the same time inhibiting effect on tumor cell lines. Therefore, it can be effectively used for the prevention and treatment of cancer overexpressing CD9.

Abstract: The present invention relates to a CD9-specific human antibody, more precisely a CD9-specific human antibody composed of human derived CD9-specific complementarity determining region (CDR) and framework region (FR). The human antibody of the present invention recognizes CD9 extracellular loop 2 domain (CD9-ECL2) as an epitope and thereby strongly binding thereto. The human antibody of the present invention also has CD9 antigen neutralizing effect and at the same time inhibiting effect on tumor cell lines. Therefore, it can be effectively used for the prevention and treatment of cancer overexpressing CD9.

Abstract: Disclosed herein are a communication terminal and a method for determining a packet retransmission time in the hand-off thereof. If a hand-off between heterogeneous communication networks with different speeds is generated, a packet retransmission time after the hand-off is determined corresponding to features of a current communication network so that an error packet can be retransmitted at a speed suitable for the corresponding handed-off communication network without waste of communication resources.

Abstract: The present invention relates to a transmembrane protease, serine (TMPRSS4)-specific human antibody, and more particularly to a human antibody including a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody specifically bound to TMPRSS4. The TMPRSS4-specific human antibody expressed in the various kinds of cancer cells of the present invention may be used in diagnosis of the cancer, classification of the disease, visualization, treatment, and prognostic evaluation.

Abstract: An earphone and method for forming the same are provided. The earphone includes an earphone housing, a speaker, and an earcap. The earphone housing includes a speaker mounting portion. The speaker is fixed to the earphone housing, and has a cable that passes through the body and is drawn from the body. The earcap is installed to at least partially enclose the speaker and the housing, and has at least one speaker sound emitting hole therein. The earcap is made of a material that solidifies after a predetermined time elapses, and is manufactured by inserting the material into an ear of a user, and then solidifying the material such that it is suited for a shape of the ear of the user.

Abstract: The present invention relates to a vascular endothelial growth factor (VEGF)-specific human antibody, and more particularly to a human antibody including a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody specifically bound to VEGF. The VEGF-specific human antibody of the present invention may be used in diagnosis of diseases caused by the VEGF-overexpression, classification of the diseases, visualization, treatment, and prognostic evaluation.

Abstract: A method of processing an incoming call failure includes receiving a notification of an incoming voice call from a mobile switching center (MSC) during a data service; transmitting the notification of the incoming voice call to a mobile station (MS) and receiving an acceptance notification of the incoming voice call from the MS; transmitting an affirmative receipt of the notification of the incoming voice call with respect to the received acceptance notification of the incoming voice call to the MSC; setting a packet paging inactive field; disregarding a packet paging when the packet paging is received from a packet control function in a dormant state; and receiving a call paging from the MSC and transmitting the call paging to the MS.